Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 258 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MANSENCAL N, Mustafic H, Hauguel-Moreau M, Lannou S, et al
    Occurrence of Atrial Fibrillation During Dobutamine Stress Echocardiography.
    Am J Cardiol. 2019 Jan 31. pii: S0002-9149(19)30114.
    PubMed     Text format     Abstract available


  2. SINGH A, Kawaji K, Goyal N, Nazir NT, et al
    Feasibility of Cardiac Magnetic Resonance Wideband Protocol in Patients With Implantable Cardioverter Defibrillators and Its Utility for Defining Scar.
    Am J Cardiol. 2019 Jan 31. pii: S0002-9149(19)30110.
    PubMed     Text format     Abstract available


  3. SOTOMI Y, Hirata A, Amiya R, Kobayashi T, et al
    Bleeding Risk of Add-On Anti-Platelet Agents to Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (From 2216 Patients in the DIRECT Registry).
    Am J Cardiol. 2019 Jan 25. pii: S0002-9149(19)30119.
    PubMed     Text format     Abstract available


  4. CHO MS, Lee K, Choi KJ, Lee JB, et al
    Thromboembolic Risk of Imaging-Confirmed Coronary Artery Disease Without Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2019 Jan 24. pii: S0002-9149(19)30115.
    PubMed     Text format     Abstract available


  5. WU L, Liang E, Fan S, Zheng L, et al
    Relation of Left Atrial Appendage Morphology Determined by Computed Tomography to Prior Stroke or to Increased Risk of Stroke in Patients With Atrial Fibrillation.
    Am J Cardiol. 2019 Jan 23. pii: S0002-9149(19)30116.
    PubMed     Text format     Abstract available


  6. PLATONOV PG, Haugaa KH, Bundgaard H, Svensson A, et al
    Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Am J Cardiol. 2019 Jan 8. pii: S0002-9149(19)30056.
    PubMed     Text format     Abstract available


  7. MANGNER N, Crusius L, Haussig S, Woitek FJ, et al
    Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation.
    Am J Cardiol. 2019 Jan 7. pii: S0002-9149(19)30045.
    PubMed     Text format     Abstract available


  8. YOON YH, Ahn JM, Kang DY, Ko E, et al
    Incidence, Predictors, Management, and Clinical Significance of New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2019 Jan 5. pii: S0002-9149(19)30044.
    PubMed     Text format     Abstract available


  9. VAMOS M, Erath JW, Benz AP, Lopes RD, et al
    Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.
    Am J Cardiol. 2019;123:69-74.
    PubMed     Text format     Abstract available


    December 2018
  10. ZHANG W, Xiong Y, Yu L, Xiong A, et al
    Meta-analysis of Stroke and Bleeding Risk in Patients with Various Atrial Fibrillation Patterns Receiving Oral Anticoagulants.
    Am J Cardiol. 2018 Dec 19. pii: S0002-9149(18)32203.
    PubMed     Text format     Abstract available


  11. NAKAMARU R, Tanaka N, Okada M, Tanaka K, et al
    Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.
    Am J Cardiol. 2018 Dec 4. pii: S0002-9149(18)32144.
    PubMed     Text format     Abstract available


  12. MECHAKRA A, Footz T, Walter M, Aranega A, et al
    A Novel PITX2c Gain-of-Function Mutation, p.Met207Val, in Patients With Familial Atrial Fibrillation.
    Am J Cardiol. 2018 Dec 3. pii: S0002-9149(18)32152.
    PubMed     Text format     Abstract available


  13. DOSHI R, Al-Khafaji JF, Dave M, Taha M, et al
    Comparison of Baseline Characteristics and In-hospital Outcomes in Medicaid Versus Private Insurance Hospitalizations for Atrial Fibrillation.
    Am J Cardiol. 2018 Dec 3. pii: S0002-9149(18)32150.
    PubMed     Text format     Abstract available


  14. HU YF, Chang SL, Chern CM, Wu CH, et al
    Bleeding and New-Onset Cancers in Patients With Atrial Fibrillation Receiving Nonvitamin K Antagonist Oral Anticoagulants.
    Am J Cardiol. 2018 Dec 3. pii: S0002-9149(18)32151.
    PubMed     Text format     Abstract available


  15. LILLI A, Tessa C, Del Meglio J, Salvatori L, et al
    Diagnostic and Prognostic Role of Cardiac Magnetic Resonance Before Implantable Cardioverter Defibrillator.
    Am J Cardiol. 2018 Dec 3. pii: S0002-9149(18)32141.
    PubMed     Text format     Abstract available


    November 2018
  16. LIP GYH, Merino JL, Banach M, de Groot JR, et al
    Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF).
    Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32100.
    PubMed     Text format     Abstract available


  17. WETMORE JB, Peng Y, Gilbertson DT, Liu J, et al
    Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.
    Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32101.
    PubMed     Text format     Abstract available


  18. VAN VEEN B, Andersen CM, Johansen JB, Theuns DA, et al
    Patient-Reported Quality of Life as a Predictor of Mortality and Ventricular Tachyarrhythmia's During 7 Years' Follow-Up in Patients With an Implantable Cardioverter Defibrillator (from the MIDAS Study).
    Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32102.
    PubMed     Text format     Abstract available


  19. BERKOVITCH A, Younis A, Grossman Y, Segev S, et al
    Relation of Neutrophil to Lymphocyte Ratio to Risk of Incident Atrial Fibrillation.
    Am J Cardiol. 2018 Nov 7. pii: S0002-9149(18)32051.
    PubMed     Text format     Abstract available


  20. KORJIAN S, Daaboul Y, Laliberte F, Zhao Q, et al
    Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis).
    Am J Cardiol. 2018 Nov 6. pii: S0002-9149(18)32048.
    PubMed     Text format     Abstract available


  21. KOENE RJ, Alraies MC, Norby FL, Soliman EZ, et al
    Relation of the CHA2DS2-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study).
    Am J Cardiol. 2018 Nov 6. pii: S0002-9149(18)32052.
    PubMed     Text format     Abstract available


    September 2018
  22. CANPOLAT U, Aytemir K
    Epicardial Fat As an Indicator of the Metabolic Syndrome Promoting Atrial Fibrillation Recurrence.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31855.
    PubMed     Text format    


  23. NIKU AD, Shiota T, Siegel RJ, Rader F, et al
    Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31848.
    PubMed     Text format     Abstract available


  24. ALDAAS OM, Malladi CL, Hsu JC
    Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31834.
    PubMed     Text format     Abstract available


  25. FU M, Qin Z, Zheng S, Li Y, et al
    Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31846.
    PubMed     Text format     Abstract available


  26. FLEDDERMANN A, Eckert R, Muskala P, Hayes C, et al
    Efficacy of Direct Acting Oral Anticoagulant Drugsin Treatment of Left Atrial Appendage Thrombusin Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31847.
    PubMed     Text format     Abstract available


  27. GUIMARAES PO, Zakroysky P, Goyal A, Lopes RD, et al
    Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31852.
    PubMed     Text format     Abstract available


  28. OLESEN KKW, Steensig K, Madsen M, Thim T, et al
    Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 26. pii: S0002-9149(18)31832.
    PubMed     Text format     Abstract available


  29. MELLES MC, Yap SC, Bhagwandien RE, Sakhi R, et al
    Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.
    Am J Cardiol. 2018 Sep 23. pii: S0002-9149(18)31764.
    PubMed     Text format     Abstract available


  30. KIZAWA S, Ito T, Akamatsu K, Ichihara N, et al
    Chronic Kidney Disease as a Possible Predictor of Left Atrial Thrombogenic Milieu Among Patients with Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 13. pii: S0002-9149(18)31763.
    PubMed     Text format     Abstract available


  31. GUO J, Guan T, Fan S, Chao B, et al
    Underuse of Oral Anticoagulants in Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Am J Cardiol. 2018 Sep 13. pii: S0002-9149(18)31762.
    PubMed     Text format     Abstract available


  32. KUO L, Chao TF, Liu CJ, Chen SJ, et al
    Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Sep 13. pii: S0002-9149(18)31761.
    PubMed     Text format     Abstract available


  33. GUEDENEY P, Chieffo A, Snyder C, Mehilli J, et al
    Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
    Am J Cardiol. 2018 Sep 8. pii: S0002-9149(18)31735.
    PubMed     Text format     Abstract available


  34. YEUNG C, Drew D, Hammond S, Hopman WM, et al
    Extended Cardiac Monitoring in Patients With Severe Sleep Apnea and No History of Atrial Fibrillation (The Reveal XT-SA Study).
    Am J Cardiol. 2018 Sep 7. pii: S0002-9149(18)31731.
    PubMed     Text format     Abstract available


    August 2018
  35. MISUMIDA N, Ogunbayo GO, Kim SM, Abdel-Latif A, et al
    Frequency and Significance of High-Degree Atrioventricular Block and Sinoatrial Node Dysfunction in Patients With Non-ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2018 Aug 21. pii: S0002-9149(18)31622.
    PubMed     Text format     Abstract available


  36. AQUARO GD, Pingitore A, Di Bella G, Piaggi P, et al
    Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Am J Cardiol. 2018 Aug 21. pii: S0002-9149(18)31637.
    PubMed     Text format     Abstract available


  37. DAVARASHVILI I, Acha MR, Glikson M, Farkash R, et al
    Pulmonary Congestion Complicating Atrial Fibrillation Cardioversion.
    Am J Cardiol. 2018 Aug 21. pii: S0002-9149(18)31641.
    PubMed     Text format     Abstract available


  38. MAEDA M, Oba K, Yamaguchi S, Arasaki O, et al
    Usefulness of Epicardial Adipose Tissue Volume to Predict Recurrent Atrial Fibrillation After Radiofrequency Catheter Ablation.
    Am J Cardiol. 2018 Aug 21. pii: S0002-9149(18)31633.
    PubMed     Text format     Abstract available


  39. THIND M, Holmes DN, Badri M, Pieper KS, et al
    Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).
    Am J Cardiol. 2018 Aug 20. pii: S0002-9149(18)31630.
    PubMed     Text format     Abstract available


  40. MCINTYRE WF, John PDS, Torabi M, Tate RB, et al
    Lifetime Pattern of Atrial Fibrillation and the Risks of Stroke and Death in a Population-based Cohort of Men (from The Manitoba Follow-Up Study).
    Am J Cardiol. 2018 Aug 20. pii: S0002-9149(18)31632.
    PubMed     Text format     Abstract available


  41. WESTCOTT SK, Beach LY, Matsushita F, Albert CM, et al
    RelationshipBetween Psychosocial Stressors and Atrial Fibrillation in Women >45 Years of Age.
    Am J Cardiol. 2018 Aug 17. pii: S0002-9149(18)31629.
    PubMed     Text format     Abstract available


  42. CHAN WK, Danon A, Wijeysundera HC, Singh SM, et al
    Single Versus Dual Lead Atrioventricular Sequential Pacing for Acquired Atrioventricular Block During Transcatheter Aortic Valve Implantation Procedures.
    Am J Cardiol. 2018;122:633-637.
    PubMed     Text format     Abstract available


  43. LOU B, Liang X, Wu Y, Deng Y, et al
    Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.
    Am J Cardiol. 2018;122:604-611.
    PubMed     Text format     Abstract available


  44. KONECNY T, Brady PA, Park JY, Reddy PK, et al
    Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea.
    Am J Cardiol. 2018 Aug 4. pii: S0002-9149(18)31502.
    PubMed     Text format     Abstract available


  45. SONG C, Guo Y, Zheng X, Lu J, et al
    Prognostic Significance and Risk of Atrial Fibrillation of Wolff-Parkinson-White Syndrome in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2018 Aug 3. pii: S0002-9149(18)31493.
    PubMed     Text format     Abstract available


  46. GOLIVE A, May HT, Bair TL, Jacobs V, et al
    The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia.
    Am J Cardiol. 2018 Aug 3. pii: S0002-9149(18)31503.
    PubMed     Text format     Abstract available


  47. ROBERT R, Porot G, Vernay C, Buffet P, et al
    Incidence, Predictive Factors, and Prognostic Impact of Silent Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2018;122:446-454.
    PubMed     Text format     Abstract available


    July 2018
  48. OGUNBAYO GO, Charnigo R, Darrat Y, Shah J, et al
    Comparison of Complications of Catheter Ablation for Ventricular Arrhythmias in Adults With Versus Without Structural Heart Disease.
    Am J Cardiol. 2018 Jul 19. pii: S0002-9149(18)31408.
    PubMed     Text format     Abstract available


  49. LOWN M, Yue AM, Shah BN, Corbett SJ, et al
    Screening for Atrial Fibrillation Using Economical and Accurate Technology (From the SAFETY Study).
    Am J Cardiol. 2018 Jul 19. pii: S0002-9149(18)31411.
    PubMed     Text format     Abstract available


  50. MAH DY, Sleeper LA, Crosson JE, Czosek RJ, et al
    Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome.
    Am J Cardiol. 2018 Jul 17. pii: S0002-9149(18)31424.
    PubMed     Text format     Abstract available


  51. SPIEKER M, Hellhammer K, Spiesshofer J, Katsianos S, et al
    Effect of Atrial Fibrillation and Mitral Valve Gradients on Response to Percutaneous Mitral Valve Repair With the MitraClip System.
    Am J Cardiol. 2018 Jul 17. pii: S0002-9149(18)31417.
    PubMed     Text format     Abstract available


  52. FREDRIKSSON T, Frykman V, Friberg L, Al-Khalili F, et al
    Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial Fibrillation.
    Am J Cardiol. 2018 Jul 4. pii: S0002-9149(18)31322.
    PubMed     Text format     Abstract available


  53. KAPLAN RM, Diaz CL, Strzelczyk T, You C, et al
    Outcomes With Novel Oral Anticoagulants in Obese Patients who Underwent Electrical Cardioversion for Atrial Tachyarrhythmias.
    Am J Cardiol. 2018 Jul 4. pii: S0002-9149(18)31314.
    PubMed     Text format     Abstract available


    June 2018
  54. GARCIA-GARCIA C, Oliveras T, Rueda F, Perez-Fernandez S, et al
    Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry).
    Am J Cardiol. 2018 Jun 27. pii: S0002-9149(18)31055.
    PubMed     Text format     Abstract available


  55. LUO X, Xiong Q, Xu J, Hong K, et al
    Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm.
    Am J Cardiol. 2018 Jun 26. pii: S0002-9149(18)31049.
    PubMed     Text format     Abstract available


  56. SEIFU SA, Ahmed J, Wilklow FE, Jain N, et al
    Type I Second Degree Atrioventricular Block in a Woman With Remote Repair of a Ventricular Septal Defect.
    Am J Cardiol. 2018 Jun 23. pii: S0002-9149(18)31236.
    PubMed     Text format     Abstract available


  57. ROBERTS WC, Kondapalli N, Hall SA
    Usefulness of Total 12-Lead QRS Voltage for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy in Patients With Heart Failure Severe Enough to Warrant Orthotopic Heart Transplantation and Morphologic Illustration of Its Cardiac Diversity.
    Am J Cardiol. 2018 Jun 22. pii: S0002-9149(18)31237.
    PubMed     Text format     Abstract available


  58. WORME MD, Tan MK, Armstrong DWJ, Yan AT, et al
    Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).
    Am J Cardiol. 2018 Jun 21. pii: S0002-9149(18)31220.
    PubMed     Text format     Abstract available


  59. ELGENDY AY, Mahmoud AN, Khan MS, Sheikh MR, et al
    Meta-Analysis Comparing Catheter-Guided Ablation Versus Conventional Medical Therapy for Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Am J Cardiol. 2018 Jun 5. pii: S0002-9149(18)31181.
    PubMed     Text format     Abstract available


  60. MOJADIDI MK, Elgendy AY, Elgendy IY, Mahmoud AN, et al
    Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure.
    Am J Cardiol. 2018 Jun 5. pii: S0002-9149(18)31208.
    PubMed     Text format    


  61. LEUNG M, Abou R, van Rosendael PJ, van der Bijl P, et al
    Relation of Echocardiographic Markers of Left Atrial Fibrosis to Atrial Fibrillation Burden.
    Am J Cardiol. 2018 Jun 4. pii: S0002-9149(18)31048.
    PubMed     Text format     Abstract available



  62. Evaluation of Gender Differences in Atrial Fibrillation-Related Risk Factors in General Chinese Population: Insights From a Large Asian Population.
    Am J Cardiol. 2018 Jun 2. pii: S0002-9149(18)31205.
    PubMed     Text format    


  63. TURIN A, Bax JJ, Doukas D, Joyce C, et al
    Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
    Am J Cardiol. 2018 Jun 2. pii: S0002-9149(18)31185.
    PubMed     Text format     Abstract available


  64. DONG X, Tang M, Sun Q, Zhang S, et al
    Usefulness of Reversed U-Curve Technique to Enhance Mapping and Ablation Efficiency in the Treatment of Pulmonary Sinus Cusp-Derived Ventricular Arrhythmias.
    Am J Cardiol. 2018 Jun 2. pii: S0002-9149(18)31182.
    PubMed     Text format     Abstract available


  65. WANG Z, Chen Z, Wang X, Zhang L, et al
    The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey.
    Am J Cardiol. 2018 Jun 2. pii: S0002-9149(18)31187.
    PubMed     Text format     Abstract available


  66. ESTEVE-PASTOR MA, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, et al
    Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Jun 2. pii: S0002-9149(18)31184.
    PubMed     Text format     Abstract available


    May 2018
  67. PARSONS C, Cha S, Shen WK, Chamberlain AM, et al
    Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation.
    Am J Cardiol. 2018 May 15. pii: S0002-9149(18)31050.
    PubMed     Text format     Abstract available


  68. ERKUNER O, Dudink EAMP, Nieuwlaat R, Rienstra M, et al
    Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Am J Cardiol. 2018 May 11. pii: S0002-9149(18)31054.
    PubMed     Text format     Abstract available


  69. INOUE YY, Ipek EG, Khurram IM, Ciuffo L, et al
    Relation of Electrocardiographic Left Atrial Abnormalities to Risk of Stroke in Patients with Atrial Fibrillation.
    Am J Cardiol. 2018 May 3. pii: S0002-9149(18)30863.
    PubMed     Text format     Abstract available


  70. O'NEAL WT, Sandesara PB, Claxton JS, MacLehose RF, et al
    Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation.
    Am J Cardiol. 2018 May 1. pii: S0002-9149(18)30945.
    PubMed     Text format     Abstract available


  71. YOUNIS A, Nof E, Israel A, Goldenberg I, et al
    Relation of Atrial Premature Complexes During Exercise Stress Testing to the Risk for the Development of Atrial Fibrillation in Patients Undergoing Cardiac Rehabilitation.
    Am J Cardiol. 2018 May 1. pii: S0002-9149(18)31019.
    PubMed     Text format     Abstract available


    April 2018
  72. SORIGUE M, Sarrate E, Franch-Sarto M, Sancho JM, et al
    Risk of Cardioembolic Stroke in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2018 Apr 18. pii: S0002-9149(18)30296.
    PubMed     Text format    


  73. BATUROVA MA, Kutyifa V, McNitt S, Polonsky B, et al
    Usefulness of Electrocardiographic Left Atrial Abnormality to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart Failure and Left Bundle Branch Block (a Multicenter Automatic Defibrillator Implantation Trial with Cardiac
    Am J Cardiol. 2018 Apr 11. pii: S0002-9149(18)30853.
    PubMed     Text format     Abstract available


  74. GUGLIN M
    Functional Classes of Heart Failure and Indications for Implantable Cardioverter-Defibrillator.
    Am J Cardiol. 2018 Apr 3. pii: S0002-9149(18)30397.
    PubMed     Text format    


    March 2018
  75. WU J, Fan X, Yang H, Yan L, et al
    Usefulness of a Low Resting Heart Rate to Predict Recurrence of Atrial Fibrillation After Catheter Ablation in People >/=65 Years of Age.
    Am J Cardiol. 2018 Mar 29. pii: S0002-9149(18)30393.
    PubMed     Text format     Abstract available


  76. MAGNUSSEN C, Ojeda FM, Wild PS, Sorensen N, et al
    Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study).
    Am J Cardiol. 2018 Mar 29. pii: S0002-9149(18)30396.
    PubMed     Text format     Abstract available


  77. OKA T, Inoue K, Tanaka K, Ninomiya Y, et al
    Left Atrial Reverse Remodeling After Catheter Ablation of Nonparoxysmal Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction.
    Am J Cardiol. 2018 Mar 29. pii: S0002-9149(18)30394.
    PubMed     Text format     Abstract available


  78. SUKSARANJIT P, Marrouche NF, Han FT, Morris A, et al
    Relation of Left Atrial Appendage Remodeling by Magnetic Resonance Imaging and Outcome of Ablation for Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 29. pii: S0002-9149(18)30395.
    PubMed     Text format     Abstract available


  79. MOURTZINIS G, Kahan T, Bengtsson Bostrom K, Schioler L, et al
    Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD]).
    Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30392.
    PubMed     Text format     Abstract available


  80. ADEGBALA O, Adejumo AC, Olakanmi O, Akinjero A, et al
    Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure.
    Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30383.
    PubMed     Text format     Abstract available


  81. HERNANDEZ I, Zhang Y, Saba S
    Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 28. pii: S0002-9149(18)30380.
    PubMed     Text format     Abstract available


  82. CHHABRA L
    Abnormal P-Wave Axis and Risk of Atrial Fibrillation: Not Just the Left Atrial Enlargement but Other Factors Also Play a Significant Role.
    Am J Cardiol. 2018 Mar 23. pii: S0002-9149(18)30264.
    PubMed     Text format    


  83. ROBERTS WC, Grayburn PA, Hall SA
    Complications of Radiofrequency Ablation for Supraventricular Tachycardia in the Wolff-Parkinson-White Syndrome Associated With Noncompaction Cardiomyopathy.
    Am J Cardiol. 2018 Mar 23. pii: S0002-9149(18)30262.
    PubMed     Text format     Abstract available


  84. LIBERMAN L, Starc TJ, Silver ES
    Usefulness of High-Dose Oral Flecainide for Termination of Recent-Onset Atrial Fibrillation in Children.
    Am J Cardiol. 2018 Mar 21. pii: S0002-9149(18)30305.
    PubMed     Text format     Abstract available


  85. SLIVNICK JA, Yeow RY, McMahon C, Paje DG, et al
    Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing Endoscopy.
    Am J Cardiol. 2018 Mar 16. pii: S0002-9149(18)30279.
    PubMed     Text format     Abstract available


  86. ABUBAKAR H, Yassin AS, Akintoye E, Bakhit K, et al
    Financial Implications and Impact of Pre-existing Atrial Fibrillation on In-Hospital Outcomes in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the National Inpatient Database).
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30288.
    PubMed     Text format     Abstract available


  87. LEE OH, Kim JS, Pak HN, Hong GR, et al
    Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30281.
    PubMed     Text format     Abstract available


  88. MELDUNI RM, Gersh BJ, Wysokinski WE, Ammash NM, et al
    Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30280.
    PubMed     Text format     Abstract available


    February 2018
  89. WANG W, Alonso A, Soliman EZ, O'Neal WT, et al
    Relation of Resting Heart Rate to Incident Atrial Fibrillation (From ARIC [Atherosclerosis Risk in Communities] Study).
    Am J Cardiol. 2018 Feb 21. pii: S0002-9149(18)30179.
    PubMed     Text format     Abstract available


  90. KHAN SU, Khan MU, Ghani AR, Lone AN, et al
    Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention.
    Am J Cardiol. 2018 Feb 14. pii: S0002-9149(18)30178.
    PubMed     Text format     Abstract available


  91. ROZEN G, Vaid J, Hosseini SM, Kaadan MI, et al
    Diagnostic Accuracy of a Novel Mobile Phone Application for the Detection and Monitoring of Atrial Fibrillation.
    Am J Cardiol. 2018 Feb 13. pii: S0002-9149(18)30177.
    PubMed     Text format     Abstract available


  92. JAAKKOLA S, Kiviniemi TO, Nuotio I, Hartikainen J, et al
    Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30180.
    PubMed     Text format     Abstract available


  93. SHULMAN E, Chudow JJ, Shah T, Shah K, et al
    Relation of Body Mass Index to Development of Atrial Fibrillation in Hispanics, Blacks, and Non-Hispanic Whites.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30181.
    PubMed     Text format     Abstract available


  94. WANG ZQ, Qiang H, Luo X, Li W, et al
    Meta-Analysis of Risk of Ventricular Arrhythmias and All-Cause Mortality in Patients With Chronic Total Occlusion of a Coronary Artery and/or Implantable Cardioverter-Defibrillator.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30184.
    PubMed     Text format     Abstract available


  95. MANSOUR M, Heist EK, Agarwal R, Bunch TJ, et al
    Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30187.
    PubMed     Text format     Abstract available


  96. WAN D, Blakely C, Branscombe P, Suarez-Fuster L, et al
    Lyme Carditis and High-Degree Atrioventricular Block.
    Am J Cardiol. 2018 Feb 7. pii: S0002-9149(18)30168.
    PubMed     Text format     Abstract available


  97. ABDUL-AZIZ AA, Altawil M, Lyon A, MacEachern M, et al
    Lifestyle Therapy for the Management of Atrial Fibrillation.
    Am J Cardiol. 2018 Feb 7. pii: S0002-9149(18)30165.
    PubMed     Text format     Abstract available


  98. FOY AJ, Mandrola J, Liu G, Naccarelli GV, et al
    Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults.
    Am J Cardiol. 2018 Feb 6. pii: S0002-9149(18)30161.
    PubMed     Text format     Abstract available


  99. LU DY, Yalcin H, Yalcin F, Zhao M, et al
    Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2018 Feb 6. pii: S0002-9149(18)30164.
    PubMed     Text format     Abstract available


  100. KHAN H, Kunutsor SK, Rauramaa R, Merchant FM, et al
    Long-Term Change in Cardiorespiratory Fitness in Relation to Atrial Fibrillation and Heart Failure (from the Kuopio Ischemic Heart Disease Risk Factor Study).
    Am J Cardiol. 2018 Feb 2. pii: S0002-9149(18)30096.
    PubMed     Text format     Abstract available


    January 2018
  101. SORIGUE M, Sarrate E, Franch-Sarto M, Santos-Gomez M, et al
    Anticoagulant Agents for Atrial Fibrillation in Cancer Patients.
    Am J Cardiol. 2018 Jan 31. pii: S0002-9149(18)30107.
    PubMed     Text format    


  102. PODOLECKI T, Lenarczyk R, Kowalczyk J, Jedrzejczyk-Patej E, et al
    Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2018 Jan 12. pii: S0002-9149(18)30057.
    PubMed     Text format     Abstract available


  103. DANESHVAR M, Desai N, Andriulli J, Ortman M, et al
    Gender Differences in Presentation, Treatment, and In-Hospital Outcome of Patients Admitted With Heart Failure Complicated by Atrial Fibrillation (from the Get With the Guidelines-Heart Failure [GWTG-HF] Registry).
    Am J Cardiol. 2018 Jan 9. pii: S0002-9149(17)31772.
    PubMed     Text format     Abstract available


  104. SINGH SM, Webster L, Qiu F, Austin PC, et al
    Effect of Electrophysiology Assessment on Mortality and Hospitalizations in Patients With New-Onset Atrial Fibrillation.
    Am J Cardiol. 2018 Jan 9. pii: S0002-9149(18)30051.
    PubMed     Text format     Abstract available


  105. MASSOULLIE G, Chouki C, Mulliez A, Rossignol P, et al
    Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database).
    Am J Cardiol. 2018 Jan 3. pii: S0002-9149(17)31931.
    PubMed     Text format     Abstract available


  106. HUSSAIN N, Gersh BJ, Gonzalez Carta K, Sydo N, et al
    Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality.
    Am J Cardiol. 2018;121:41-49.
    PubMed     Text format     Abstract available


    December 2017
  107. CAVALLARI I, Patti G
    Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2017 Dec 25. pii: S0002-9149(17)31932.
    PubMed     Text format     Abstract available


  108. KAWJI MM, Glancy DL
    Syncope, Junctional Premature Complexes, and Pseudo-Type II Atrioventricular Block.
    Am J Cardiol. 2017 Dec 23. pii: S0002-9149(17)31935.
    PubMed     Text format     Abstract available


  109. GARG L, Agrawal S, Agarwal M, Shah M, et al
    Influence of Atrial Fibrillation on Outcomes in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2017 Dec 22. pii: S0002-9149(17)31917.
    PubMed     Text format     Abstract available


  110. ELBADAWI A, Elgendy IY, Ha LD, Baig B, et al
    In-Hospital Cerebrovascular Outcomes of Patients With Atrial Fibrillation and Cancer (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Dec 20. pii: S0002-9149(17)31852.
    PubMed     Text format     Abstract available


  111. ROWIN EJ, Maron MS, Chan RH, Hausvater A, et al
    Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2017;120:2256-2264.
    PubMed     Text format     Abstract available


  112. FREEMAN JV, Tabada GH, Reynolds K, Sung SH, et al
    Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation.
    Am J Cardiol. 2017 Dec 14. pii: S0002-9149(17)31859.
    PubMed     Text format     Abstract available


  113. PERERA KS, Pearce LA, Sharma M, Benavente O, et al
    Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]).
    Am J Cardiol. 2017 Dec 11. pii: S0002-9149(17)31853.
    PubMed     Text format     Abstract available


  114. KO D, Preis SR, Lubitz SA, McManus DD, et al
    Relation of Orthostatic Hypotension With New-Onset Atrial Fibrillation (From the Framingham Heart Study).
    Am J Cardiol. 2017 Dec 11. pii: S0002-9149(17)31861.
    PubMed     Text format     Abstract available


  115. BITON Y, Rosero S, Moss A, Zareba W, et al
    Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.
    Am J Cardiol. 2017 Dec 11. pii: S0002-9149(17)31857.
    PubMed     Text format     Abstract available


  116. BISSON A, Bodin A, Clementy N, Babuty D, et al
    Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort.
    Am J Cardiol. 2017 Dec 2. pii: S0002-9149(17)31774.
    PubMed     Text format     Abstract available


    November 2017
  117. LIP GYH, Merino JL, Dan GA, Themistoclakis S, et al
    Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
    Am J Cardiol. 2017 Nov 20. pii: S0002-9149(17)31616.
    PubMed     Text format     Abstract available


  118. ELLENBOGEN KA, Wan C, Shavelle DM
    Outcome of Patients With In-Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator.
    Am J Cardiol. 2017 Nov 16. pii: S0002-9149(17)31614.
    PubMed     Text format     Abstract available


  119. WANG M, Szepietowska B, Polonsky B, McNitt S, et al
    Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
    Am J Cardiol. 2017 Nov 13. pii: S0002-9149(17)31618.
    PubMed     Text format     Abstract available


  120. KOBAYASHI A, Misumida N
    Prediction of Delayed Atrioventricular Block and Pacemaker Implantation After Transcatheter Aortic Valve Replacement With CoreValve.
    Am J Cardiol. 2017 Nov 6. pii: S0002-9149(17)31693.
    PubMed     Text format    


  121. ALONSO P, Sanz J, Garcia-Orts A, Reina S, et al
    Usefulness of Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Resynchronization Therapy.
    Am J Cardiol. 2017;120:1584-1588.
    PubMed     Text format     Abstract available


    October 2017
  122. EXTRAMIANA F, Stordeur B, Furioli V, Gandjbakhch E, et al
    Spectrum and Outcome of Patients Who Have Undergone Implantation of an Implantable Cardioverter Defibrillator After Aborted-Sudden Cardiac Arrest.
    Am J Cardiol. 2017 Oct 20. pii: S0002-9149(17)31608.
    PubMed     Text format     Abstract available


  123. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients with Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Oct 20. pii: S0002-9149(17)31623.
    PubMed     Text format    


  124. GARG PK, O'Neal WT, Ogunsua A, Thacker EL, et al
    Usefulness of the American Heart Association's Life Simple 7 to Predict the Risk of Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study).
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31615.
    PubMed     Text format     Abstract available


  125. LOBO R, Jaffe AS, Cahill C, Blake O, et al
    Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter.
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31617.
    PubMed     Text format     Abstract available


  126. PICCINI JP, Sanders P, Shah R, Roberts G, et al
    Impact of Tachyarrhythmia Detection Rate and Time from Detection to Shock on Outcomes in Nationwide US Practice.
    Am J Cardiol. 2017;120:1325-1331.
    PubMed     Text format     Abstract available


  127. MUGNAI G, Hunuk B, Hernandez-Ojeda J, Stroker E, et al
    Role of Electrocardiographic Tpeak-Tend for the Prediction of Ventricular Arrhythmic Events in the Brugada Syndrome.
    Am J Cardiol. 2017;120:1332-1337.
    PubMed     Text format     Abstract available


  128. CALISKAN E, Salzberg SP, Emmert MY
    Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting-The Surgeon's Comment.
    Am J Cardiol. 2017 Oct 12. pii: S0002-9149(17)31589.
    PubMed     Text format    


  129. NISHIMURA M, Hsu JC
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Am J Cardiol. 2017 Oct 12. pii: S0002-9149(17)31602.
    PubMed     Text format     Abstract available


  130. GOLDENBERG I, Barsheshet A, Laish-Farkash A, Swissa M, et al
    Anemia and the Risk of Life-threatening Ventricular Tachyarrhythmias from the Israeli Implantable Cardioverter Defibrillator Registry.
    Am J Cardiol. 2017 Oct 5. pii: S0002-9149(17)31461.
    PubMed     Text format     Abstract available


    September 2017
  131. PATELL R, Gutierrez A, Rybicki L, Khorana AA, et al
    Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2017 Sep 20. pii: S0002-9149(17)31457.
    PubMed     Text format     Abstract available


  132. REIFFEL JA
    The R-Wave Sign as a Predictor of Ventricular Tachyarrhythmias in Brugada Syndrome: The Criteria Need Verification and Clarification.
    Am J Cardiol. 2017 Sep 19. pii: S0002-9149(17)31477.
    PubMed     Text format    


  133. RIVERA-CARAVACA JM, Marin F, Esteve-Pastor MA, Rana-Miguez P, et al
    Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Sep 19. pii: S0002-9149(17)31459.
    PubMed     Text format     Abstract available


  134. PRIHADI EA, Leung M, Vollema EM, Ng ACT, et al
    Prevalence and Prognostic Relevance of Ventricular Conduction Disturbances in Patients With Aortic Stenosis.
    Am J Cardiol. 2017 Sep 18. pii: S0002-9149(17)31469.
    PubMed     Text format     Abstract available


  135. DENDRAMIS G, Paleologo C, Sgarito G, Giordano U, et al
    Anesthetic and Perioperative Management of Patients With Brugada Syndrome.
    Am J Cardiol. 2017;120:1031-1036.
    PubMed     Text format     Abstract available


  136. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    A Clinical Score Model to Predict Lethal Events in Young Patients (</=19 Years) With the Brugada Syndrome.
    Am J Cardiol. 2017;120:797-802.
    PubMed     Text format     Abstract available


    August 2017
  137. SZE E, Dunning A, Loring Z, Atwater BD, et al
    Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31373.
    PubMed     Text format     Abstract available


  138. RAGAB AAY, Houck CA, van der Does LJME, Lanters EAH, et al
    Impact of Supraventricular Tachyarrhythmia in Patients With Inherited Cardiac Arrhythmia.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31386.
    PubMed     Text format     Abstract available


  139. MAHESHWARI A, Norby FL, Soliman EZ, Koene R, et al
    Refining Prediction of Atrial Fibrillation Risk in the General Population With Analysis of P-Wave Axis (from the Atherosclerosis Risk in Communities Study).
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31385.
    PubMed     Text format     Abstract available


  140. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31383.
    PubMed     Text format     Abstract available


  141. JACKSON SL, Tong X, Yin X, George MG, et al
    Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31387.
    PubMed     Text format     Abstract available


  142. WILLIAMS BA, Honushefsky AM, Berger PB
    Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31384.
    PubMed     Text format     Abstract available


  143. VELU JF, Kortlandt FA, Hendriks T, Schurer RAJ, et al
    Comparison of Outcome After Percutaneous Mitral Valve Repair With the MitraClip in Patients With Versus Without Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31392.
    PubMed     Text format     Abstract available


  144. DURHAM TA, Hassmiller Lich K, Viera AJ, Fine JP, et al
    Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 12. pii: S0002-9149(17)31297.
    PubMed     Text format     Abstract available


  145. ELGENDY AY, Mahtta D, Barakat AF, Abuzaid A, et al
    Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31302.
    PubMed     Text format     Abstract available


  146. SOCIE P, Nicot F, Baudinaud P, Estagnasie P, et al
    Frequency of Recovery from Complete Atrioventricular Block After Cardiac Surgery.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31296.
    PubMed     Text format     Abstract available


  147. HERNANDEZ I, Zhang Y, Saba S
    Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31298.
    PubMed     Text format     Abstract available


  148. GLEVA MJ, Wang Y, Curtis JP, Berul CI, et al
    Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR(R) Implantable Cardioverter-Defibrillator Registry).
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31309.
    PubMed     Text format     Abstract available


  149. KOSMIDOU I, Embacher M, McAndrew T, Dizon JM, et al
    Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31286.
    PubMed     Text format     Abstract available


  150. CHEN ST, Hellkamp AS, Becker RC, Berkowitz SD, et al
    Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
    Am J Cardiol. 2017 Aug 7. pii: S0002-9149(17)31301.
    PubMed     Text format     Abstract available


  151. BREAUX DM, Glancy DL
    Sinus Tachycardia With Variable QRS Morphology.
    Am J Cardiol. 2017;120:511.
    PubMed     Text format     Abstract available


  152. BAI Y, Shi XB, Ma CS, Lip GYH, et al
    Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.
    Am J Cardiol. 2017 Aug 1. pii: S0002-9149(17)31245.
    PubMed     Text format     Abstract available


  153. DADEKIAN G, Kaplan AV, Chang CH, Morden NE, et al
    Atrial Fibrillation and Stent Selection (Bare Metal vs Drug Eluting) (from Medicare Claims).
    Am J Cardiol. 2017 Aug 1. pii: S0002-9149(17)31225.
    PubMed     Text format     Abstract available


    July 2017
  154. LIU T, Hui J, Hou YY, Zou Y, et al
    Meta-Analysis of Efficacy and Safety of Low-Intensity Warfarin Therapy for East Asian Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31223.
    PubMed     Text format     Abstract available


  155. YAO X, Gersh BJ, Sangaralingham LR, Kent DM, et al
    Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31224.
    PubMed     Text format     Abstract available


  156. HIOKI H, Watanabe Y, Kozuma K, Nara Y, et al
    Timing of Susceptibility to Mortality and Heart Failure in Patients With Preexisting Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31234.
    PubMed     Text format     Abstract available


  157. SHANTHA GPS, Mentias A, Bhise V, Kumar A, et al
    Gender Differences in the Trends of Hospitalizations for Acute Stroke Among Patients With Atrial Fibrillation in the United States: 2005 to 2014.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31217.
    PubMed     Text format     Abstract available


  158. AKHABUE E, Seok Park C, Pinney S, Anyanwu A, et al
    Usefulness of Speckle Tracking Strain Echocardiography for Assessment of Risk of Ventricular Arrhythmias After Placement of a Left Ventricular Assist Device.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31229.
    PubMed     Text format     Abstract available


  159. JOY PS, Gopinathannair R, Olshansky B
    Effect of Ablation for Atrial Fibrillation on Heart Failure Readmission Rates.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31230.
    PubMed     Text format     Abstract available


  160. KHURSHID S, Weng LC, Hulme OL, Ellinor PT, et al
    Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31181.
    PubMed     Text format     Abstract available


  161. WIESEL J, Salomone TJ
    Screening for Atrial Fibrillation in Patients >/=65 Years Using an Automatic Blood Pressure Monitor in a Skilled Nursing Facility.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31180.
    PubMed     Text format     Abstract available


  162. DARKNER S, Goetze JP, Chen X, Henningsen K, et al
    Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31182.
    PubMed     Text format     Abstract available


  163. SOLIMAN EZ, Zhang ZM, Judd S, Howard VJ, et al
    Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31165.
    PubMed     Text format     Abstract available


  164. LOIKAS D, Forslund T, Wettermark B, Schenck-Gustafsson K, et al
    Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants.
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31166.
    PubMed     Text format     Abstract available


  165. WILSON HC, Hopkin RJ, Madueme PC, Czosek RJ, et al
    Arrhythmia and Clinical Cardiac Findings in Children With Anderson-Fabry Disease.
    Am J Cardiol. 2017;120:251-255.
    PubMed     Text format     Abstract available


  166. ADMASSIE E, Chalmers L, Bereznicki LR
    Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31117.
    PubMed     Text format     Abstract available


  167. DINESEN PT, Joensen AM, Rix TA, Tjonneland A, et al
    Effect of Dietary Intake of Saturated Fatty Acids on the Development of Atrial Fibrillation and the Effect of Replacement of Saturated With Monounsaturated and Polyunsaturated Fatty Acids.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31115.
    PubMed     Text format     Abstract available


  168. ZULKIFLY H, Lip GYH, Lane DA
    Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31120.
    PubMed     Text format     Abstract available


  169. IOANNOU A, Papageorgiou N, Barber H, Falconer D, et al
    Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31118.
    PubMed     Text format     Abstract available


  170. TRENKWALDER T, King R, Kaess BM, Hengstenberg C, et al
    Ventricular and Supraventricular Ectopy in Subjects With Early Repolarization.
    Am J Cardiol. 2017;120:92-97.
    PubMed     Text format     Abstract available


  171. RODES-CABAU J, O'Hara G, Paradis JM, Bernier M, et al
    Changes in Coagulation and Platelet Activation Markers Following Transcatheter Left Atrial Appendage Closure.
    Am J Cardiol. 2017;120:87-91.
    PubMed     Text format     Abstract available


  172. HONG C, Alluri K, Shariff N, Khattak F, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Mortality in Defibrillator Recipients.
    Am J Cardiol. 2017;120:83-86.
    PubMed     Text format     Abstract available


    June 2017
  173. INOUE K, Suna S, Iwakura K, Oka T, et al
    Outcomes for Atrial Fibrillation Patients with Silent Left Atrial Thrombi Detected by Transesophageal Echocardiography.
    Am J Cardiol. 2017 Jun 29. pii: S0002-9149(17)31030.
    PubMed     Text format     Abstract available


  174. IGLESIAS-ALVAREZ D, Rodriguez-Manero M, Garcia-Seara FJ, Kreidieh O, et al
    Comparison and Validation of Recommended QT Interval Correction Formulas for Predicting Cardiac Arrhythmias in Patients With Advanced Heart Failure and Cardiac Resynchronization Devices.
    Am J Cardiol. 2017 Jun 29. pii: S0002-9149(17)31032.
    PubMed     Text format     Abstract available


  175. ELBADAWI A, Ogunbayo GO, Elgendy IY, Olorunfemi O, et al
    Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting (From the National Inpatient Sample Database).
    Am J Cardiol. 2017 Jun 28. pii: S0002-9149(17)31033.
    PubMed     Text format     Abstract available


  176. CLOUTIER JM, Liu S, Hiebert B, Tam JW, et al
    Relationship of Extreme Cold Weather and Implantable Cardioverter Defibrillator Shocks.
    Am J Cardiol. 2017 Jun 28. pii: S0002-9149(17)31039.
    PubMed     Text format     Abstract available


  177. SHIMADA YJ, Tsugawa Y, Camargo CA Jr, Brown DFM, et al
    Effect of Bariatric Surgery on Emergency Department Visits and Hospitalizations for Atrial Fibrillation.
    Am J Cardiol. 2017 Jun 27. pii: S0002-9149(17)31034.
    PubMed     Text format     Abstract available


  178. LIP GYH, Al-Saady N, Jin J, Sun M, et al
    Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30957.
    PubMed     Text format     Abstract available


  179. O'NEAL WT, Kamel H, Judd SE, Safford MM, et al
    Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30962.
    PubMed     Text format     Abstract available


  180. ASHBURNER JM, Singer DE, Lubitz SA, Borowsky LH, et al
    Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30956.
    PubMed     Text format     Abstract available


  181. TAKAHASHI M, Mouillet G, Deballon R, Sudre A, et al
    Impact of QRS Duration on Decision of Early Removal of Pacing Catheter After Transcatheter Aortic Valve Replacement With CoreValve Device.
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30950.
    PubMed     Text format     Abstract available


  182. VIDULA H, Kutyifa V, McNitt S, Goldenberg I, et al
    Long-Term Survival of Patients With Left Bundle Branch Block Who Are Hypo-Responders to Cardiac Resynchronization Therapy.
    Am J Cardiol. 2017 Jun 13. pii: S0002-9149(17)30941.
    PubMed     Text format     Abstract available


  183. SILBERBERG A, Tan MK, Yan AT, Angaran P, et al
    Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Netw
    Am J Cardiol. 2017 Jun 1. pii: S0002-9149(17)30863.
    PubMed     Text format     Abstract available


  184. KOTTMAIER M, Bourier F, Reents T, Reiter A, et al
    Safety and Feasibility of Subcutaneous Purse-String Suture of the Femoral Vein After Electrophysiological Procedures on Uninterrupted Oral Anticoagulation.
    Am J Cardiol. 2017;119:1781-1784.
    PubMed     Text format     Abstract available


    May 2017
  185. GLANCY DL, Helmcke FR, Hoang AP
    Bradycardia, Syncope, and Left Ventricular Noncompaction Cardiomyopathy.
    Am J Cardiol. 2017 May 30. pii: S0002-9149(17)30880.
    PubMed     Text format     Abstract available


  186. PODOLECKI T, Lenarczyk R, Kowalczyk J, Jedrzejczyk-Patej E, et al
    Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2017 May 30. pii: S0002-9149(17)30853.
    PubMed     Text format     Abstract available


  187. INOHARA T, Kimura T, Ueda I, Ikemura N, et al
    Effect of Compliance to Updated AHA/ACC Performance and Quality Measures Among Patients With Atrial Fibrillation on Outcome (from Japanese Multicenter Registry).
    Am J Cardiol. 2017 May 30. pii: S0002-9149(17)30865.
    PubMed     Text format     Abstract available


  188. WASHAM JB, Hellkamp AS, Lokhnygina Y, Piccini JP, et al
    Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
    Am J Cardiol. 2017 May 29. pii: S0002-9149(17)30862.
    PubMed     Text format     Abstract available


  189. BOLIN EH, Lang SM, Tang X, Collins RT, et al
    Propranolol Versus Digoxin in the Neonate for Supraventricular Tachycardia (from the Pediatric Health Information System).
    Am J Cardiol. 2017;119:1605-1610.
    PubMed     Text format     Abstract available


  190. LEMPEREUR M, Aminian A, Freixa X, Gafoor S, et al
    Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Am J Cardiol. 2017 May 12. pii: S0002-9149(17)30782.
    PubMed     Text format     Abstract available


  191. RAGAB AAY, Houck CA, van der Does LJME, Lanters EAH, et al
    Usefulness of the R-Wave Sign as a Predictor for Ventricular Tachyarrhythmia in Patients With Brugada Syndrome.
    Am J Cardiol. 2017 May 11. pii: S0002-9149(17)30780.
    PubMed     Text format     Abstract available


  192. SHAH RR, Pillai A, Schafer P, Meggo D, et al
    Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30777.
    PubMed     Text format     Abstract available


  193. MASUDA M, Fujita M, Iida O, Okamoto S, et al
    Association Between Local Bipolar Voltage and Conduction Gap Along the Left Atrial Linear Ablation Lesion in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30778.
    PubMed     Text format     Abstract available


  194. MUNIR MB, Sharbaugh MS, Ahmad S, Patil S, et al
    Causes and Predictors of 30-Day Readmissions in Atrial Fibrillation (from the Nationwide Readmissions Database).
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30776.
    PubMed     Text format     Abstract available


  195. KARGOLI F, Shulman E, Aagaard P, Briceno DF, et al
    Socioeconomic Status as a Predictor of Mortality in Patients Admitted With Atrial Fibrillation.
    Am J Cardiol. 2017;119:1378-1381.
    PubMed     Text format     Abstract available


  196. DE ASMUNDIS C, Mugnai G, Chierchia GB, Sieira J, et al
    Long-Term Follow-Up of Probands With Brugada Syndrome.
    Am J Cardiol. 2017;119:1392-1400.
    PubMed     Text format     Abstract available


  197. MAHESHWARI A, Norby FL, Soliman EZ, Alraies MC, et al
    Relation of Prolonged P-Wave Duration to Risk of Sudden Cardiac Death in the General Population (from the Atherosclerosis Risk in Communities Study).
    Am J Cardiol. 2017;119:1302-1306.
    PubMed     Text format     Abstract available


  198. EGBE AC, Asirvatham SJ, Connolly HM, Kapa S, et al
    Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease.
    Am J Cardiol. 2017;119:1468-1472.
    PubMed     Text format     Abstract available


  199. MCCARTHY CP, Yousuf O, Alonso A, Selvin E, et al
    High-Sensitivity Troponin as a Biomarker in Heart Rhythm Disease.
    Am J Cardiol. 2017;119:1407-1413.
    PubMed     Text format     Abstract available


    April 2017
  200. RIJNIERSE MT, Kamali Sadeghian M, Schuurmans Stekhoven S, Biesbroek PS, et al
    Usefulness of Left Atrial Emptying Fraction to Predict Ventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillators.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30703.
    PubMed     Text format     Abstract available


  201. SMER A, Saurav A, Azzouz MS, Salih M, et al
    Meta-analysis of Risk of Ventricular Arrhythmias After Improvement in Left Ventricular Ejection Fraction During Follow-Up in Patients With Primary Prevention Implantable Cardioverter Defibrillators.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30708.
    PubMed     Text format     Abstract available


  202. KUMAGAI N, Nusser JA, Inoue H, Okumura K, et al
    Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30699.
    PubMed     Text format     Abstract available


  203. EBRAHIM MA, Williams MR, Shepard S, Perry JC, et al
    Genotype Positive Long QT Syndrome in Patients With Coexisting Congenital Heart Disease.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30706.
    PubMed     Text format     Abstract available


  204. MUGNAI G, de Asmundis C, Iacopino S, Stroker E, et al
    Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30700.
    PubMed     Text format     Abstract available


  205. LAUBE ES, Yu A, Gupta D, Miao Y, et al
    Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30697.
    PubMed     Text format     Abstract available


  206. HUANG G, Parikh PB, Malhotra A, Gruberg L, et al
    Relation of Body Mass Index and Gender to Left Atrial Size and Atrial Fibrillation.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30701.
    PubMed     Text format     Abstract available


  207. GUO X, Li Z, Guo L, Yu S, et al
    Effects of Metabolically Healthy and Unhealthy Obesity on Prolongation of Corrected QT Interval.
    Am J Cardiol. 2017;119:1199-1204.
    PubMed     Text format     Abstract available


  208. GUPTA R, Tichnell C, Murray B, Rizzo S, et al
    Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Am J Cardiol. 2017 Apr 13. pii: S0002-9149(17)30622.
    PubMed     Text format     Abstract available


  209. GOLIVE A, May HT, Bair TL, Jacobs V, et al
    The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30627.
    PubMed     Text format     Abstract available


  210. GUO Y, Wu X, Zheng X, Lu J, et al
    Usefulness of Preoperative Transforming Growth Factor-Beta to Predict New Onset Atrial Fibrillation After Surgical Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30623.
    PubMed     Text format     Abstract available


  211. KAWJI MM, Glancy DL
    An 18-Year-Old Woman Who Was Found Down.
    Am J Cardiol. 2017;119:1124-1125.
    PubMed     Text format     Abstract available


    March 2017
  212. ELBADAWI A, Olorunfemi O, Ogunbayo GO, Saad M, et al
    Cardiovascular Outcomes With Surgical Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation Who Underwent Valvular Heart Surgery (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30361.
    PubMed     Text format     Abstract available


  213. BALLA SR, Cyr DD, Lokhnygina Y, Becker RC, et al
    Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30352.
    PubMed     Text format     Abstract available


  214. WANG M, Zhao Q, Ding W, Cai S, et al
    Comparison of Direct Current Synchronized Cardioversion to Ibutilide-Guided Catheter Ablation for Long-Term Sinus Rhythm Maintenance After Isolated Pulmonary Vein Isolation of Persistent Atrial Fibrillation.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30351.
    PubMed     Text format     Abstract available


  215. STEINBERG BA, Simon DN, Thomas L, Ansell J, et al
    Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fib
    Am J Cardiol. 2017 Mar 28. pii: S0002-9149(17)30201.
    PubMed     Text format     Abstract available


  216. LEE Y, Park HC, Lee Y, Kim SG, et al
    Comparison of Morphologic Features and Flow Velocity of the Left Atrial Appendage Among Patients With Atrial Fibrillation Alone, Transient Ischemic Attack, and Cardioembolic Stroke.
    Am J Cardiol. 2017 Mar 19. pii: S0002-9149(17)30202.
    PubMed     Text format     Abstract available


  217. ROWIN EJ, Orfanos A, Estes NA, Wang W, et al
    Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30275.
    PubMed     Text format     Abstract available


  218. O'NEAL WT, Sandesara P, Hammadah M, Venkatesh S, et al
    Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30282.
    PubMed     Text format     Abstract available


  219. SASSONE B, Bertini M, Beltrami M, Malagu M, et al
    Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30279.
    PubMed     Text format     Abstract available


  220. BOSE A, O'Neal WT, Bennett A, Judd SE, et al
    Relation Between Estimated Cardiorespiratory Fitness and Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30285.
    PubMed     Text format     Abstract available


  221. TOMOMATSU T, Morishima I, Okumura K, Tsuboi H, et al
    Comparison of Frequency and Characteristics of Patients With Atrial Fibrillation Having Ablation With Versus Without Coronary Narrowing (>/=50%) by Angiography.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30286.
    PubMed     Text format     Abstract available


  222. CHERIAN TS, Shrader P, Fonarow GC, Allen LA, et al
    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30289.
    PubMed     Text format     Abstract available


  223. FRANKLIN SM, Thihalolipavan S, Fontaine JM
    Sinus Bradycardia in Habitual Cocaine Users.
    Am J Cardiol. 2017 Mar 1. pii: S0002-9149(17)30204.
    PubMed     Text format     Abstract available


  224. D'ASCENZI F, Solari M, Anselmi F, Valentini F, et al
    Electrocardiographic Changes Induced by Endurance Training and Pubertal Development in Male Children.
    Am J Cardiol. 2017;119:795-801.
    PubMed     Text format     Abstract available


  225. KAWJI MM, Glancy DL
    Repeat the Electrocardiogram!
    Am J Cardiol. 2017;119:816-817.
    PubMed     Text format     Abstract available


    February 2017
  226. GEORGE J, Abdulla RK, Yeow R, Aggarwal A, et al
    Daily Energy Expenditure and Its Relation to Health Care Costs in Patients Undergoing Ambulatory Electrocardiographic Monitoring.
    Am J Cardiol. 2017;119:658-663.
    PubMed     Text format     Abstract available


  227. POKORNEY SD, Mi X, Hammill BG, Allen LaPointe NM, et al
    Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30129.
    PubMed     Text format     Abstract available


  228. CONROTTO F, Salizzoni S, Andreis A, D'Ascenzo F, et al
    Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30141.
    PubMed     Text format     Abstract available


  229. AKSU T, Guler TE, Yalin K, Golcuk SE, et al
    A Novel Deep Inspiration Maneuver for Difficult Transseptal Puncture.
    Am J Cardiol. 2017;119:428-433.
    PubMed     Text format     Abstract available


    January 2017
  230. AGARWAL V, Vittinghoff E, Whitman IR, Dewland TA, et al
    Relation Between Ventricular Premature Complexes and Incident Heart Failure.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30052.
    PubMed     Text format     Abstract available


  231. RIAD FS, Davis AM, Moranville MP, Beshai JF, et al
    Drug-Induced QTc Prolongation.
    Am J Cardiol. 2017;119:280-283.
    PubMed     Text format     Abstract available


  232. BAGUR R, Chamula M, Brouillard E, Lavoie C, et al
    Radiotherapy-Induced Cardiac Implantable Electronic Device Dysfunction in Patients With Cancer.
    Am J Cardiol. 2017;119:284-289.
    PubMed     Text format     Abstract available


  233. EL-CHAMI MF, Merchant FM, Leon AR
    Leadless Pacemakers.
    Am J Cardiol. 2017;119:145-148.
    PubMed     Text format     Abstract available


    December 2016
  234. TONIOLO M, Rebellato L, Poli S, Daleffe E, et al
    Efficacy and Safety of Catheter Ablation of Atrial Tachycardia Through a Direct Approach from Noncoronary Sinus of Valsalva.
    Am J Cardiol. 2016;118:1847-1854.
    PubMed     Text format     Abstract available


  235. NORTON L, Tsiperfal A, Cook K, Bagdasarian A, et al
    Effectiveness and Safety of an Independently Run Nurse Practitioner Outpatient Cardioversion Program (2009 to 2014).
    Am J Cardiol. 2016;118:1842-1846.
    PubMed     Text format     Abstract available


  236. FREIXA X, Llull L, Gafoor S, Cruz-Gonzalez I, et al
    Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.
    Am J Cardiol. 2016;118:1836-1841.
    PubMed     Text format     Abstract available


  237. ARORA S, Patel P, Lahewala S, Patel N, et al
    Etiologies, Trends, and Predictors of 30-Day Readmission in Patients With Heart Failure.
    Am J Cardiol. 2016 Dec 14. pii: S0002-9149(16)31891.
    PubMed     Text format     Abstract available


  238. HUNG RK, Al-Mallah MH, Whelton SP, Michos ED, et al
    Effect of Beta-Blocker Therapy, Maximal Heart Rate, and Exercise Capacity During Stress Testing on Long-Term Survival (from The Henry Ford Exercise Testing Project).
    Am J Cardiol. 2016;118:1751-1757.
    PubMed     Text format     Abstract available


  239. LIP GY, Waldo AL, Ip J, Martin DT, et al
    Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Am J Cardiol. 2016;118:1680-1684.
    PubMed     Text format     Abstract available


    November 2016
  240. LEE MJ, Jang JH, Lee MD, Kwon SW, et al
    Prognostic Implications of Newly Developed T-Wave Inversion After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31807.
    PubMed     Text format     Abstract available


  241. YANG L, Sun G, Chen X, Chen G, et al
    Meta-Analysis of Zero or Near-Zero Fluoroscopy Use During Ablation of Cardiac Arrhythmias.
    Am J Cardiol. 2016;118:1511-1518.
    PubMed     Text format     Abstract available


  242. BOBBO M, Pinamonti B, Merlo M, Stolfo D, et al
    Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Am J Cardiol. 2016 Nov 11. pii: S0002-9149(16)31725.
    PubMed     Text format     Abstract available


    October 2016
  243. PINA IL, Carson P, Lindenfeld J, Archambault WT, et al
    Persistence of 123I-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial).
    Am J Cardiol. 2016 Oct 31. pii: S0002-9149(16)31735.
    PubMed     Text format     Abstract available


    September 2016
  244. MOORE JA, Cabrera AG, Kim JJ, Valdes SO, et al
    Follow-Up of Electrocardiographic Findings and Arrhythmias in Patients With Anomalously Arising Left Coronary Artery from the Pulmonary Trunk.
    Am J Cardiol. 2016 Sep 23. pii: S0002-9149(16)31382.
    PubMed     Text format     Abstract available


    August 2016
  245. O'NEAL WT, Wang YG, Wu HT, Zhang ZM, et al
    Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study).
    Am J Cardiol. 2016 Aug 20. pii: S0002-9149(16)31118.
    PubMed     Text format     Abstract available


  246. PEDERSEN SS, Mastenbroek MH, Carter N, Barr C, et al
    A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy).
    Am J Cardiol. 2016;118:520-6.
    PubMed     Text format     Abstract available


  247. BIAGINI E, Pazzi C, Olivotto I, Musumeci B, et al
    Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2016;118:432-9.
    PubMed     Text format     Abstract available


  248. JACOBSSON J, Borgquist R, Reitan C, Ghafoori E, et al
    Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization Therapy.
    Am J Cardiol. 2016;118:389-95.
    PubMed     Text format     Abstract available


    July 2016
  249. PATEL NJ, Pau D, Nalluri N, Bhatt P, et al
    Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31234.
    PubMed     Text format     Abstract available


  250. TISMINETZKY M, Chen HY, McManus DD, Gurwitz J, et al
    Trends in the Magnitude of, and Patient Characteristics Associated With, Multiple Hospital Readmissions After Acute Myocardial Infarction.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31237.
    PubMed     Text format     Abstract available


  251. CASTILLO-MORENO JA, Garcia-Escribano IA, Martinez-Pascual-de-Riquelme M, Jaulent-Huertas L, et al
    Prognostic Usefulness of the 6-Minute Walk Test in Patients With Severe Aortic Stenosis.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31251.
    PubMed     Text format     Abstract available


  252. MACDONALD MR, Wee PP, Cao Y, Yang DM, et al
    Comparison of Characteristics and Outcomes of Heart Failure Patients With Preserved Versus Reduced Ejection Fraction in a Multiethnic Southeast Asian Cohort.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31248.
    PubMed     Text format     Abstract available


  253. TAKAHASHI H, Jimbo Y, Takano H, Abe H, et al
    Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Am J Cardiol. 2016;118:222-5.
    PubMed     Text format     Abstract available


  254. WEIDEMANN F, Maier SK, Stork S, Brunner T, et al
    Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
    Am J Cardiol. 2016;118:264-74.
    PubMed     Text format     Abstract available


  255. ATHER S, Shendre A, Beasley TM, Brown T, et al
    Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
    Am J Cardiol. 2016;118:232-6.
    PubMed     Text format     Abstract available


  256. GLANCY DL
    Narrow-QRS and Wide-QRS Tachycardias.
    Am J Cardiol. 2016;118:146-8.
    PubMed     Text format     Abstract available


    May 2016
  257. KAPLON-CIESLICKA A, Tyminska A, Peller M, Balsam P, et al
    Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30949.
    PubMed     Text format     Abstract available


  258. EMDIN CA, Odutayo A, Wong CX, Tran J, et al
    Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease.
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30944.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: